Dr Phillip Daniel Brooks, MD | |
650 Joel Dr, Blanchfield Army Community Hospital, Ft. Campbell, KY 42223-5349 | |
(270) 798-8372 | |
Not Available |
Full Name | Dr Phillip Daniel Brooks |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 650 Joel Dr, Ft. Campbell, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790751022 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 46386-020 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Phillip Daniel Brooks, MD 650 Joel Dr, Blanchfield Army Community Hospital, Ft. Campbell, KY 42223-5349 Ph: (270) 798-8372 | Dr Phillip Daniel Brooks, MD 650 Joel Dr, Blanchfield Army Community Hospital, Ft. Campbell, KY 42223-5349 Ph: (270) 798-8372 |
News Archive
ERYTECH Pharma has just completed the enrollment of patients in a Phase I clinical trial with its flagship product for pancreatic cancer, Graspa®. This product contains the enzyme L-asparaginase encapsulated in red blood cells, using technology owned by ERYTECH Pharma.
College of Science associate professor and researcher David Feliciano has received a $667,000 grant from the Department of Defense to explore the cellular underpinnings of Tuberous Sclerosis Complex (TSC), a developmental disorder characterized by the growth of benign tumors throughout the body, most notably in the brain.
Two biophysicists from Case Western Reserve University School of Medicine have used supercomputers to show how cell membranes control the shape, and consequently the function, of a major cancer-causing protein.
A study has shown that undertreatment of chronic obstructive pulmonary disease is highly prevalent.
› Verified 3 days ago